Zobrazeno 1 - 10
of 15
pro vyhledávání: '"E. Boullosa‐Graña"'
Autor:
C. Barrios, C. Blesa, José María Moreno-Planas, A. Moreno-Zamora, E. Oton, A. Moreno, Valentín Cuervas-Mons, M. Garcia-Gonzalez, E. Boullosa‐Graña, S. Garcia-Garzon, Rafael Bárcena, M. L. Mateos, E. E. Rubio‐Gonzalez
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 6(10)
Hepatitis C recurrence after liver transplantation (LT) is universal, and frequently leads to cirrhosis and death. The aim of our study was to assess the efficacy and safety of 48-weeks of full-dose peg-interferon-alpha-2a (n = 4) or alpha-2b (n = 51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e3683a430f516ea364d42cd28b3d7a7
https://pubmed.ncbi.nlm.nih.gov/16869810
https://pubmed.ncbi.nlm.nih.gov/16869810
Autor:
J.M. Moreno Planas, E. Rubio González, J.L. Lucena de la Poza, M. Fernández Ruiz, V. Cuervas-Mons Martı́nez, M. Jiménez Garrido, F. Martı́nez Arrieta, V. Sánchez Turrión, E. Boullosa Graña, C. Molina Miliani
Publikováno v:
Transplantation proceedings. 37(3)
Clearance of HCV before transplantation could avoid recurrence of hepatitis C in the liver allograft, thereby improving graft and patient survival. We report our experience with combined therapy for patients with HCV cirrhosis, including 12 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c01e14ad84bdcb009e0a96f4af4b48a
https://pubmed.ncbi.nlm.nih.gov/15866647
https://pubmed.ncbi.nlm.nih.gov/15866647
Autor:
J.M. Moreno Planas, E. Rubio González, V. Cuervas-Mons Martı́nez, J.L. Lucena de la Poza, C. Barrios Peinado, A. Garrido Botella, M. Jiménez Garrido, V. Sánchez Turrión, E. Boullosa Graña
Publikováno v:
Transplantation Proceedings. 37:2207-2208
The objective of the study was to assess the efficacy of antiviral therapy in patients with hepatitis C virus (HCV) recurrence after liver transplantation (OLT). We included 30 patients of mean age 56 years, who experienced HCV recurrence after OLT.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eee754f195e221ddbce8ab3512c03df
https://doi.org/10.1016/j.transproceed.2005.03.124
https://doi.org/10.1016/j.transproceed.2005.03.124
Autor:
E. Rubio González, M. Fernández Ruiz, J.M. Moreno Planas, R. Pérez Arangüena, J.L. Pérez-Picouto, A. Gómez Cruz, E. Boullosa Graña, V. Sánchez Turrión, A. Garcia Suarez, V. Cuervas-Mons Martı́nez, J.L. Lucena de la Poza, J. López Monclús
Publikováno v:
Transplantation Proceedings. 37:1484-1485
The aim of this study was to evaluate the efficacy of different locoregional therapies in patients with HCC on the waiting list for liver transplantation. From October 2001 to July 2003, 13 patients, all men, with HCC diagnosed by cytology, were tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::040fac1d19a97199ab171a6a83224ff2
https://doi.org/10.1016/j.transproceed.2005.02.042
https://doi.org/10.1016/j.transproceed.2005.02.042
Autor:
Valentín Cuervas-Mons, M. Acevedo Ribó, D Sanz Guajardo, E. Boullosa Graña, J.M. Moreno Planas, E. Rubio Gonzalez, V. Sánchez-Turrión, C. Sanz Moreno, E. Rubio González
Publikováno v:
Transplantation Proceedings. 37:1480-1481
Introduction Pruritus is the most disabling symptom in patients with cholestatic liver diseases. Many drug therapies have been used for the treatment of these diseases, with different outcomes. The molecular adsorbent recirculating system (MARS) has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e410f5c2a36f98b7f324062d3f1c61d3
https://doi.org/10.1016/j.transproceed.2005.02.002
https://doi.org/10.1016/j.transproceed.2005.02.002
Autor:
E. Rubio González, J.M. Moreno Planas, S. Martı́n Garcia, M. Fernández Ruiz, F. Portero Azorin, V. Cuervas-Mons Martı́nez, F. Martı́nez Arrieta, M. Jiménez Garrido, V. Sánchez Turrión, E. Boullosa Graña
Publikováno v:
Transplantation Proceedings. 37:1486-1487
Introduction Among the at least six major identified genotypes of HCV, genotype 1b, the one associated with a poorer prognosis, is the most prevalent in Spain. We aimed to compare the distribution of hepatitis C virus genotypes in our liver transplan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e261893d6b0be9de0d56b50a8c0279
https://doi.org/10.1016/j.transproceed.2005.02.050
https://doi.org/10.1016/j.transproceed.2005.02.050
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Moreno Planas JM; Liver Transplant Unit, Hospital Puerta de Hierro, Madrid, Spain. josemariamoren@mixmail.com, Rubio González E, Boullosa Graña E, Fernández Ruiz M, Jiménez Garrido M, Lucena de la Poza JL, Martínez Arrieta F, Molina Miliani C, Sánchez Turrión V, Cuervas-Mons Martínez V
Publikováno v:
Transplantation proceedings [Transplant Proc] 2005 Apr; Vol. 37 (3), pp. 1482-3.